12 Health Care Stocks Moving In Thursday's After-Market Session

-3.19% Post

-2.21% Post

-4.44% Post

-10.05% Post

-2.75% Post

AquaBounty Technologies Inc

AQB

0.78

0.77

-3.19%

-1.92% Post

Accuray Incorporated

ARAY

1.33

-2.21%

0.00% Post

CINGULATE INC.

CING

4.52

-4.44%

0.00% Post

China Pharma Holdings, Inc.

CPHI

1.70

1.78

-10.05%

+4.71% Post

CEL-SCI Corporation

CVM

3.53

3.45

-2.75%

-2.27% Post

Gainers

cbdMD (AMEX:YCBD) shares increased by 16.5% to $0.92 during Thursday's after-market session. The market value of their outstanding shares is at $2.7 million. The company's, Q4 earnings came out 4 days ago.
CEL-SCI (AMEX:CVM) shares increased by 8.7% to $3.09. The market value of their outstanding shares is at $154.2 million.
DermTech (NASDAQ:DMTK) stock moved upwards by 7.38% to $1.89. The company's market cap stands at $64.7 million.
China Pharma Holding (AMEX:CPHI) stock moved upwards by 6.55% to $0.13. The market value of their outstanding shares is at $4.2 million.
Accuray (NASDAQ:ARAY) shares rose 5.84% to $3.08. The market value of their outstanding shares is at $298.9 million.
Yield10 Bioscience (NASDAQ:YTEN) stock rose 5.08% to $0.25. The company's market cap stands at $2.9 million.

Losers

Cingulate (NASDAQ:CING) shares declined by 14.9% to $8.33 during Thursday's after-market session. The market value of their outstanding shares is at $7.8 million.
Microbot Medical (NASDAQ:MBOT) shares fell 9.27% to $1.86. The company's market cap stands at $21.7 million.
T2 Biosystems (NASDAQ:TTOO) shares fell 8.06% to $6.85. The market value of their outstanding shares is at $27.7 million.
SenesTech (NASDAQ:SNES) stock declined by 7.52% to $1.6. The company's market cap stands at $1.2 million.
NKGen Biotech (NASDAQ:NKGN) shares fell 7.17% to $2.85. The market value of their outstanding shares is at $62.3 million.
AquaBounty Techs (NASDAQ:AQB) shares decreased by 6.15% to $2.75. The market value of their outstanding shares is at $10.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.